Cystic Papillary Thyroid Carcinoma: A Case Report

Darwin Totesora, Ma. Theresa Chua-Agcaoili


The malignant potential of cystic nodule(s) should never be overlooked in certain select patients even if it carries a low chance of malignancy. The diagnosis of PTC relies primarily on the typical nuclear features, however in cases of histologic uncertainty, immunohistochemical stains such as HBME-1 may be used to help classify unusual presentations of PTC. Treatment and monitoring of Cystic Papillary Thyroid Carcinoma follows the conventional guideline on solid PTC.


cystic papillary thyroid carcinoma, HBME-1, papillary thyroid carcinoma

Full Text:

Abstract HTML PDF


Haugen BR, Alexander EK, Bible KC et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133. PMID: 26462967. PMCID: PMC4739132.

Raboca-Carlos J, Kho SA, et al. The Philippine Thyroid Disease Study (PhilTiDes1): Prevalance of thyroid disorders among adults in the Philippines. J ASEAN Fed of Endocr Soc. 2012;27(1): 27-33.

Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National

Cancer data base report on 53, 856 cases of thyroid carcinoma treated in the US from 1985-1995. Cancer. 1998;83(12):2638-48. PMID: 9874472.<2638::aidcncr31>;2-1.

Lo TE, Uy AT, Maningat PD. Well-differentiated thyroid cancer: The Philippine General Hospital experience. Endocrinol Metab (Seoul). 2016;31(1):72-9. PMID: 26754584. PMCID: PMC4803565.

Ross D. Cystic thyroid nodules. UpToDate. https://www.uptodate.


de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules. The dilemma of malignant lesions. Arch Intern Med. 1990;150(7):1422-7. PMID: 2196027.

Pathology and genetics of tumors of the endocrine organs, 3rd ed. WHO classification of tumours, vol. 8, DeLellis RA, Lloyd RV, Heitz PU, ed.; 2004.

Hapke MR, Dehner LP, The optically clear nucleus: A reliable sign of papillary thyroid carcinoma of the thyroid. Am J Surg Pathol.

;31(1):31-8. PMID: 534382.


Liu H and Lin F. Application of immunohistochemistry in thyroid

pathology. Arch Pathol Lab Med. 2015;139(1):67-82. PMID: 25549145.

Scognamiglio T, Hyjek E, Kao J, Chen YT. Diagnostic usefulness of HBME-1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma. Am J Clin Pathol. 2006;126(5):700-8. PMID: 17050067.

Erdogan-Durmus S, Ozcan D, Yarikkaya E, Kurt A, Arsian A.

CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid

carcinoma and nodular thyroid lesions. J Res Med Sci. 2016; 21:49.

PMID: 27904595. PMCID: PMC5121990.

Nasr MR, Mukhopadhyay S, Zhang S, et al. Immunohistochemical markers in diagnosis of Papillary Thyroid Carcinoma: Utility of HBME-1 combined with CK19 immunohistostaining. Mod Pathol. 2006;19(12):1631-7. PMID: 16998461.

Patil VS, Vijayakumar A, Natikar N. Unusual presentation of cystic papillary thyroid carcinoma. Case Rep Endocrinol. PMID: 23133761.PMCID: PMC3485764.

Baser B, Munjal VR, Roy MT. Papillary carcinoma of the thyroid

with unusual presentation. Indian J Otolaryngol Head Neck Surg.

;67(suppl 1):145-8. PMID: 25621272. PMCID: PMC4298624.

Pratinidhi S, Panda S, Das D. Papillary thyroid carcinoma presented as cystic neck mass: A rare presentation. Indian Journal of Clinical Practice. 2014; 24(4): 339-41.

Rahmat F, Kumar A, Muthu AKM, Gopal NSR, Han SJ, Yahaya AS. Papillary thyroid carcinoma as a lateral neck cyst: A cystic metastatic node versus an ectopic thyroid tissue. Case Rep Endocrinol. 2018;2018:5198297. PMID: 30420925. PMCID: PMC6211211.